Zenas BioPharma, Inc. Common Stock (ZBIO NASDAQ) stock market data APIs
$18.3026
3.54(19.3%)
as of September 16, 2025
Try our APIs with
free plan!
Zenas BioPharma, Inc. Common Stock Financial Data Overview
Price chart is built with
Anychart
Zenas BioPharma, Inc., a clinical-stage biopharmaceutical company, engages in the development and commercialization of transformative immunology-based therapies. Its lead product candidate is obexelimab, a bifunctional monoclonal antibody designed to bind CD19 and Fc"RIIb for the treatment of various I&I diseases and various indications, including immunoglobulin G4-related disease, multiple sclerosis, and systemic lupus erythematosus. The company also develops ZB002, an anti-TNFa monoclonal antibody; ZB004, a cytotoxic T-lymphocyte-associated antigen 4-immunoglobulin fusion; and ZB001, an anti-IGF-1R monoclonal antibody. The company was formerly known as Zenas BioPharma (Cayman) Limited and changed its name to Zenas BioPharma, Inc. in August 2023. The company was incorporated in 2019 and is headquartered in Waltham, Massachusetts.
Prev. Close
18.3026
Open
21.8394
High
22.0818
Low
18.3026
52 wk Range
5.83-26.251
Market Cap
924 M
Shares Outstanding
42 110 K
Revenue
15 000 K
EPS
-1.25
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Zenas BioPharma, Inc. Common Stock (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Zenas BioPharma, Inc. Common Stock data using free add-ons & libraries
Get Zenas BioPharma, Inc. Common Stock Fundamental Data
Zenas BioPharma, Inc. Common Stock Fundamental data includes:
- Net Revenue: 15 000 K
- EBITDA: -188 996 992
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-08-12
- EPS/Forecast: -1.06
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Zenas BioPharma, Inc. Common Stock News
New
Zenas BioPharma and Royalty Pharma enter into Obexelimab funding agreement for $300M
* Zenas BioPharma (NASDAQ:ZBIO [https://seekingalpha.com/symbol/ZBIO]), and Royalty Pharma (RPRX [https://seekingalpha.com/symbol/RPRX]) announced [https://seekingalpha.com/pr/20217104-zenas-biophar...
Royalty Pharma and Zenas BioPharma Enter Into Obexelimab Funding Agreement for Up to $300 Million
Initial $75 million to fund the potential U.S. commercial launch of obexelimab for the treatment of IgG4-Related DiseaseAdditional $150 million associated with the upcoming results of the obexelimab P...
Royalty Pharma and Zenas BioPharma Enter Into Obexelimab Funding Agreement for Up to $300 Million
Royalty Pharma plc Initial $75 million to fund the potential U.S. commercial launch of obexelimab for the treatment of IgG4-Related Disease Additional $150 million associated with the upcoming result...
Zenas BioPharma and Royalty Pharma Enter into Obexelimab Funding Agreement for up to $300 Million
Zenas BioPharma - Initial $75 million to fund the potential U.S. commercial launch of obexelimab for the treatment of IgG4-Related Disease - - Additional $150 million associated with the upcoming re...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
